DroneShield Ltd (ASX: DRO) shares have continued to slide over the past month.

During this time, the counter-drone technology company’s shares have lost almost 20% of their value.

But that doesn’t reflect a lack of progress from the company. In fact, there have been a number of announcements over the period.

And one that could have flown under the radar from this week relates to its European operations.

Let’s take a closer look at what the company has announced.

What did DroneShield announce?

On Tuesday, DroneShield announced the launch of a strategic supply chain campaign in Poland, which aims to strengthen local industry engagement and support the delivery of next-generation sovereign and allied counter-drone capability across Europe.

The company revealed that the campaign will see DroneShield expand engagement with Polish manufacturing and technology partners to drive a more resilient and scalable supply chain.

This is aligned with growing European demand for counter-uncrewed aircraft systems (CUAS).

DroneShield advised that the initiative is intended to support European military, public safety, and critical infrastructure customers that are seeking proven counter-drone solutions with strong local industrial participation.

The campaign is being timed to coincide with the release of DroneShield’s accompanying European supply chain expansion document. This document will outline its approach to working with Polish partners across areas including advanced manufacturing, subsystem supply, electronics, testing, sustainment, and capability integration.

‘An important strategic market’

Commenting on the plans, DroneShield’s Europe-based technical and supply chain manager, Ciaran Mannion, said:

Poland is an important strategic market for DroneShield and a natural fit for deeper industrial collaboration. This campaign reflects our commitment to working with capable local partners to support European requirements with proven counter-drone technology, responsive delivery, and sovereign capability.

As demand for counter-drone capability continues to grow, customers are increasingly looking for trusted suppliers who can combine world-class technology with strong local industrial support. Our Polish supply chain campaign is designed to help meet that need.

The company notes that the Polish supply chain campaign forms part of its broader international growth strategy. It reflects DroneShield’s focus on building durable partnerships in priority markets where national security, defence modernisation, and critical infrastructure protection remain key policy and procurement priorities.

Despite recent share price weakness, DroneShield’s shares are still beating the market over the past 12 months. During this time, they have generated a 41% return for investors. So, it isn’t all doom and gloom.

The post Own DroneShield shares? Here’s some news you might have missed appeared first on The Motley Fool Australia.

More reading

• DroneShield shares lifting off on Monday amid big leadership news
• Here are the 10 most shorted ASX shares
• 8 ASX shares with 30% to 220% upside ahead: Experts
• Own DroneShield shares? Here’s some big news
• What on earth’s going on with DroneShield shares?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended DroneShield. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

CSL Ltd (ASX: CSL) shares ended in the red again at the close of the ASX on Tuesday afternoon.

The shares ended around 1% lower for the day, at $112.04 a piece and they’re now around 4% lower over the past week. It looks like investor sentiment has started softening again.

The shares began rebounding through the first three weeks of June, and are still around 19% higher than an all-time low of just $92.24 earlier in the month.

But CSL shares are still 35% lower year to date and 54% lower than this time last year.

The question now is, if you own the ASX healthcare shares, what should you do with them?

Is it time to buy more in the dip? Hold tight until we know what will happen next? Or sell up before the shares drop to a new low?

Here’s what the experts think.

Are CSL shares a buy, sell or hold?

Analysts are divided on the outlook for CSL shares, although the majority agree there should be some upside ahead.

Market Index data shows most brokers (five out of seven) have a hold rating on CSL shares. However, the $137.04 target price implies a potential 22% upside at the time of writing.

TradingView data also shows that, of 18 analysts, 10 have a hold rating and another eight have a buy or strong buy rating on the stock. 

The average $138.48 target price implies a potential 25% upside at the time of writing. However, some analysts tip the ASX healthcare shares to fall around 8% to $103.49, while others forecast CSL to jump around 76% higher to $197.66, at the time of writing.

UBS recently renewed its buy rating on CSL shares with a 12-month price target of $158. The broker is feeling more positive about the company’s outlook, and believes that this year could mark the low point for CSL’s earnings.

But the team at Peak Asset Management is more bearish and is one of the brokers with a sell rating on the ASX stock. 

The broker said that the biotech giant has materially downgraded its FY26 outlook while announcing about $5 billion of additional non-cash pre-tax impairments across fiscal years 2026 and 2027. It also noted that the CSL Vifor acquisition has underperformed amid government healthcare cost pressures and a higher-interest-rate environment.

Meanwhile, Ord Minnett recently confirmed its hold rating and $117 target price on CSL shares. The broker also said it believes the market is underestimating the challenges its Vifor business is facing and expects earnings to be below consensus estimates.

My view of CSL shares

I don’t think things look too good for CSL shares right now, and short-term growth appears to be limited.

Over the longer term, I think there is still potential. CSL’s growth initiatives seem to be working, and it is operating in a dominant position in a high-growth market.

I think it’s possible that if CSL can turn around its financials, investor confidence will follow. But until then, I’m holding tight. 

The post Down 54%: What should I do with my CSL shares now? appeared first on The Motley Fool Australia.

More reading

• Is this broker right about CSL shares?
• 3 cheap ASX shares that could be hiding in plain sight
• Why A2 Milk, Calix, CSL, and Ioneer shares are charging higher today
• Down 53%, is it time to throw in the towel on CSL shares?
• Should I buy CSL and ResMed shares right now?

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Premier Investments Ltd (ASX: PMV) looks like one of Australia’s top shares to consider, given the growth in its business yet lower valuation.

As the chart below shows, the Premier Investments share price is down by 35% since September 2025, despite a bit of recovery in recent weeks.

Premier Investments has three important contributors to its value – Peter Alexander, Smiggle and a large stake of Breville Group Ltd (ASX: BRG.

It’s true that the business faces tougher trading conditions with higher interest rates and stronger inflation, potentially affecting both customers and the company’s cost base.

But, I think the hefty decline has been overdone and seems to assume major, long-term impacts. I think this is an opportunity to invest in one of Australia’s top shares, particularly given Peter Alexander’s prospects.

Strong prospects for Peter Alexander

A few months ago, the pyjamas business reported that in the first half of FY26, it delivered sales growth of 4.9% to $312.3 million. Since the first half of FY20, the business has grown sales at a compound annual growth rate (CAGR) of 13.7%

Peter Alexander continues to invest in its retail channel, delivering good growth within its existing markets of Australia and New Zealand.

It noted that it opened four new stores in the first half of FY26, with one in Victoria and three in NSW.

The company also noted that four existing stores were relocated and/or expanded during the first half of FY26, with investment in upgraded store fitouts aiming to significantly improve the customer shopping experience. Of those four stores, three were in Victoria and one was in New Zealand.

It was noted that more than 15 additional opportunities have been identified for both new and/or larger-format stores in existing markets to better showcase the wider product offering.

I’m particularly excited by the fact that this division has established a presence in the UK, which has a large addressable market. It started with a few stores in London and could continue growing in the years ahead. The growth prospects here make it one of Australia’s top shares to consider, in my view.

It also said it’s exploring international wholesale opportunities with global, quality wholesale partners.

Smiggle is struggling at the moment, but Premier Investment is looking to reset the business and I don’t think the market is considering the fact that conditions could improve.

Finally, Breville has proven itself over the years and continues to expand geographically into markets such as China, South Korea and the Middle East. I’m glad Premier Investments still owns this holding.

Valuation and dividend yield

This looks like one of Australia’s top shares, in my opinion, and its valuation is very compelling.

Based on the FY26 projection on Commsec, the Premier Investments share price is valued at 15x FY26’s estimated earnings with a possible grossed-up dividend yield of 7.5%, including franking credits, at the time of writing. This seems far too cheap to me.

I’m excited about the long-term potential of the business, as well as a few other ASX shares that could help us outperform.

The post A rare buying opportunity in 1 of Australia’s top shares? appeared first on The Motley Fool Australia.

More reading

• 3 top ASX dividend shares to buy with 5% to 7% yields
• Here are the top 10 ASX 200 shares today
• Why did ASX 200 retail shares lead the market last week?

Motley Fool contributor Tristan Harrison has positions in Breville Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Premier Investments. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.